Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model

Authors

John D. Morrey, Utah State University
Venkatraman Siddharthan, Utah State University
Aaron L. Olsen, Utah State University
Hong Wang, Utah State University
Justin G. Julander, Utah State University
Jeffery O. Hall, Utah State University
Hua Li, MacroGenics, Inc.
Jeffrey L. Nordstrom, MacroGenics, Inc.
Scott Koenig, MacroGenics, Inc.
Syd Johnson, MacroGenics, Inc.
Michael S. Diamond, Washington University School of Medicine in St. LouisFollow

Journal

Antimicrobial Agents and Chemotherapy

Publication Date

2007

Volume

51

Issue

7

Inclusive Pages

2396

Document Type

Open Access Publication

DOI

10.1128/AAC.00147-07

Rights and Permissions

Morrey, J. D., Siddharthan, V., Olsen, A. L., Wang, H., Julander, J. G., Hall, J. O., . . . Diamond, M. S. (2007). Defining limits of treatment with humanized neutralizing monoclonal antibody for west nile virus neurological infection in a hamster model. Antimicrobial Agents and Chemotherapy, 51(7), 2396-2402.DOI: 10.1128/AAC.00147-07

Recommended Citation

Morrey, John D.; Siddharthan, Venkatraman; Olsen, Aaron L.; Wang, Hong; Julander, Justin G.; Hall, Jeffery O.; Li, Hua; Nordstrom, Jeffrey L.; Koenig, Scott; Johnson, Syd; and Diamond, Michael S., "Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model." Antimicrobial Agents and Chemotherapy. 51, 7. 2396. (2007).
https://digitalcommons.wustl.edu/open_access_pubs/2366